cardiac - Nursing Case Study

Pathophysiology

• Primary mechanism: Coronary artery disease (CAD) leads to reduced blood flow to the myocardium, causing ischemia. This impairs oxygen and nutrient delivery, potentially resulting in myocardial infarction if the blockage is severe or prolonged.

• Secondary mechanism: Heart failure occurs when the heart's pumping ability declines due to weakened or stiffened cardiac muscle, often following ischemic damage. This results in inadequate circulation to meet the body's needs, causing fluid retention, edema, and fatigue.

• Key complication: Arrhythmias can arise from ischemia or heart failure, disrupting the heart's electrical activity. This can lead to irregular heartbeats, increasing the risk of stroke, cardiac arrest, and sudden cardiac death.

Patient Profile

Demographics:

58-year-old male, construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia

• Current medications: Lisinopril, Metformin, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing chest pain and shortness of breath

• Key symptoms: Fatigue, palpitations, dizziness, mild swelling in ankles

• Vital signs: Blood pressure 150/95 mmHg, Heart rate 105 bpm, Respiratory rate 22 breaths per minute, Temperature 98.6°F, Oxygen saturation 92% on room air

Section 1

As the nurse conducts an initial assessment, several concerning findings are noted that warrant further investigation. The patient appears anxious and diaphoretic, with labored breathing evident from the use of accessory muscles. On auscultation, there are crackles in the bilateral lung bases, suggesting pulmonary congestion. Jugular venous distention is observed, which, combined with the ankle edema, indicates fluid overload consistent with decompensated heart failure. The patient's heart sounds reveal an S3 gallop, a sign often associated with increased ventricular filling pressures and heart failure.

Given these findings, the healthcare team orders an urgent set of diagnostic tests, including an electrocardiogram (ECG), which shows ST-segment depression, suggesting myocardial ischemia. Laboratory results reveal elevated troponin levels, confirming myocardial injury. A chest X-ray shows cardiomegaly and pulmonary vascular congestion. Additionally, a B-type natriuretic peptide (BNP) test is significantly elevated at 800 pg/mL, supporting a diagnosis of acute heart failure exacerbation.

The patient's status necessitates immediate intervention. The healthcare team initiates oxygen therapy, increasing the patient's oxygen saturation to 96%. Intravenous diuretics are administered to reduce fluid overload, and nitroglycerin is given to alleviate chest pain and improve coronary blood flow. Despite these measures, the patient begins to exhibit signs of a new complication: frequent premature ventricular contractions (PVCs), indicating potential progression to a more serious arrhythmia. Continuous cardiac monitoring is implemented as the team prepares for potential advanced cardiac life support measures, if necessary. This evolving scenario requires vigilant monitoring and adjustment of the treatment plan to prevent further deterioration.

Section 2

As the patient's condition is closely monitored, the healthcare team notes a change in patient status that demands immediate attention. Despite initial interventions, the patient begins to exhibit increased respiratory distress with a respiratory rate climbing to 32 breaths per minute. The patient's oxygen saturation, previously stable at 96%, drops to 88% despite supplemental oxygen. On auscultation, the crackles in the lung bases have progressed to diffuse bilateral crackles, indicating worsening pulmonary edema. The patient becomes increasingly anxious and reports a sensation of drowning, a hallmark of acute respiratory failure secondary to heart failure exacerbation.

In response to these concerning changes, the team reassesses the patient's hemodynamic status. Blood pressure has dropped to 90/60 mmHg, and heart rate remains elevated at 120 beats per minute, reflecting a possible transition to cardiogenic shock. The latest arterial blood gas analysis shows a pH of 7.30, PaCO2 of 50 mmHg, and PaO2 of 55 mmHg, indicating respiratory acidosis with hypoxemia. These findings suggest that despite diuresis, the patient's cardiac output may not be sufficient to meet the body's demands, necessitating a reevaluation of the current treatment strategy.

Given the severity of the situation, the healthcare team considers the initiation of positive airway pressure support, such as continuous positive airway pressure (CPAP), to improve oxygenation and reduce the work of breathing. Additionally, inotropic support with agents like dobutamine may be warranted to enhance cardiac contractility and stabilize hemodynamics. The team discusses these options, weighing the risks and benefits, and prepares to adjust the treatment plan accordingly. The urgency of the situation underscores the need for rapid decision-making and collaborative efforts to prevent further deterioration and guide the patient towards stabilization.

Section 3

As the healthcare team implements CPAP therapy to alleviate the patient's respiratory distress, there is a slight improvement in oxygen saturation, which rises to 92%. However, the patient's anxiety persists, and the feeling of drowning remains overwhelming. Inotropic support with dobutamine is initiated at a low dose to enhance cardiac output. Over the next hour, the patient's heart rate stabilizes at 110 beats per minute, and blood pressure improves to 100/65 mmHg. Despite these encouraging signs, the patient's urinary output remains low at 15 mL/hr, suggesting ongoing poor perfusion and potential acute kidney injury.

In light of these developments, the team orders a series of diagnostic tests to further evaluate the patient's condition. A repeat echocardiogram reveals a reduced ejection fraction of 30%, indicating significant left ventricular dysfunction. Laboratory results show elevated levels of B-type natriuretic peptide (BNP) at 1200 pg/mL, confirming severe heart failure exacerbation. Additionally, serum creatinine levels have risen to 2.0 mg/dL from a baseline of 1.2 mg/dL, corroborating the suspicion of renal impairment due to decreased cardiac output.

Faced with these findings, the healthcare team discusses the need for a more aggressive therapeutic approach. They consider titrating the dobutamine dose to optimize cardiac output while carefully monitoring for arrhythmias and further hemodynamic instability. The team also deliberates on the potential need for advanced interventions, such as intra-aortic balloon pump support or transfer to a higher level of care for potential mechanical circulatory support. The need for vigilant monitoring and rapid response to any new complications is clear, as the team works to stabilize the patient's condition and prevent further organ dysfunction.

Section 4

As the healthcare team monitors the patient's response to the adjusted interventions, there is a notable change in the patient's status. Approximately two hours after the dobutamine dose is titrated, the patient's heart rate remains stable at 105 beats per minute, and blood pressure sustains at 105/70 mmHg, suggesting some stabilization of hemodynamics. However, the patient's respiratory distress becomes more pronounced, with increased work of breathing and accessory muscle use evident. Oxygen saturation begins to decline again, dropping to 88%, despite the continued use of CPAP.

A new set of arterial blood gases (ABGs) reveals a concerning shift: the pH is now 7.31, indicating a respiratory acidosis with a partial metabolic compensation. PaCO2 has risen to 55 mmHg, and PaO2 is at 55 mmHg, reflecting worsening hypoxemia and hypercapnia. These changes suggest that the patient is experiencing increasing respiratory failure, likely due to the progression of heart failure leading to pulmonary congestion and edema.

In light of these developments, the healthcare team is prompted to reassess the airway management strategy. The persistent respiratory distress and declining ABGs indicate a potential need for intubation and mechanical ventilation to relieve the work of breathing and correct the gas exchange abnormalities. The team carefully weighs the risks and benefits, considering the patient's overall clinical picture and the potential impact of further interventions on cardiac function. As they prepare to communicate with the patient and family about the possible escalation of care, the importance of timely and decisive action to prevent further deterioration becomes increasingly clear.

Section 5

As the healthcare team reviews the patient's deteriorating respiratory status, they decide to proceed with endotracheal intubation and initiate mechanical ventilation to address the severe hypoxemia and hypercapnia. Despite sedation and successful intubation, the patient's condition continues to evolve. A post-intubation chest X-ray reveals bilateral pulmonary infiltrates, consistent with pulmonary edema, supporting the suspicion of worsening heart failure contributing to respiratory compromise.

Shortly thereafter, a repeat set of laboratory tests is drawn, including a comprehensive metabolic panel and a B-type natriuretic peptide (BNP) level. The metabolic panel shows a further decline in bicarbonate levels to 18 mEq/L, reflecting ongoing metabolic acidosis, while the BNP level has significantly increased to 1200 pg/mL, indicative of severe cardiac strain and fluid overload. These findings prompt the team to consider the possibility of acute decompensated heart failure as a central factor in the patient's respiratory deterioration.

With the new diagnostic results in hand, the team initiates a continuous infusion of a diuretic to aggressively manage the pulmonary congestion and reduce cardiac preload. They also adjust the ventilator settings to optimize oxygenation while minimizing cardiac workload. As they continue to monitor the patient's response to these interventions, they remain vigilant for signs of further complications, such as renal impairment due to diuretic therapy or arrhythmias secondary to electrolyte imbalances, recognizing that timely adjustments will be essential to stabilizing the patient's condition.